Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$18.01 - $28.32 $6,015 - $9,458
-334 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$19.76 - $29.89 $6,599 - $9,983
334 New
334 $9,000
Q2 2020

Jul 29, 2020

SELL
$7.84 - $23.29 $2,618 - $7,778
-334 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$15.51 - $17.61 $31 - $35
2 Added 0.6%
334 $6,000
Q4 2018

Feb 14, 2019

BUY
$14.52 - $19.72 $29 - $39
2 Added 0.61%
332 $6,000
Q3 2018

Nov 14, 2018

BUY
$14.85 - $16.35 $44 - $49
3 Added 0.92%
330 $5,000
Q2 2018

Aug 14, 2018

BUY
$13.8 - $16.8 $41 - $50
3 Added 0.93%
327 $5,000
Q1 2018

May 15, 2018

BUY
$13.8 - $16.2 $41 - $48
3 Added 0.93%
324 $5,000
Q4 2017

Feb 14, 2018

BUY
$13.55 - $15.8 $27 - $31
2 Added 0.63%
321 $4,000
Q3 2017

Nov 15, 2017

BUY
$13.45 - $14.35 $4,290 - $4,577
319
319 $5,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.